Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 131,943	$ 31,893
General and administrative	41,324	11,109
Total operating expenses	173,267	43,002
Loss from operations	(173,267)	(43,002)
Other income (expense):
Change in fair value of preferred stock tranche liability		(17,030)
Interest income	172	49
Interest expense	(1,428)	(28)
Total other expense, net	(1,256)	(17,009)
Net loss	$ (174,523)	$ (60,011)
Net loss per common share, basic and diluted	$ (4.64)	$ (3.40)
Weighted average common shares outstanding, basic and diluted	37,650,566	17,665,683